NovAccess Global Inc. (OTCMKTS:XSNX – Get Free Report) saw a large drop in short interest in March. As of March 15th, there was short interest totalling 400 shares, a drop of 98.3% from the February 29th total of 24,000 shares. Based on an average daily trading volume, of 972,800 shares, the days-to-cover ratio is currently 0.0 days.
NovAccess Global Price Performance
Shares of XSNX opened at $0.01 on Thursday. NovAccess Global has a 1-year low of $0.01 and a 1-year high of $0.22. The company has a 50-day moving average of $0.02 and a 200 day moving average of $0.04. The firm has a market capitalization of $245,975.40, a price-to-earnings ratio of -0.08 and a beta of 1.57.
NovAccess Global (OTCMKTS:XSNX – Get Free Report) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.01 EPS for the quarter.
NovAccess Global Company Profile
NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
Further Reading
- Five stocks we like better than NovAccess Global
- Profitably Trade Stocks at 52-Week Highs
- Best Bear Market Funds: Top 3 Investment Options to Consider
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Is DraftKings A Good Bet Ahead of Q1 Earnings?
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Mid-Cap Stocks to Outperform the Market This Cycle
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.
